Dr Paul Dowling

Biography

Dr Paul Dowling is currently woking as an Lecturer in Department of Biology under Maynooth University. Career profile (Education and Employment): BSc (University College Dublin, Pharmacology Dept.); PhD (NUI Maynooth, Biology Dept.) Academic Experience: Lecturing, Practical class supervision, Workgroup supervision: University College Dublin, Pharmacology Dept. 2001-2002; Lecturing, Practical class supervision, Workgroup supervision: NUI Maynooth, Biology Dept. 2002-2003; Lecturing, Supervision of post-graduate students, Practical class supervision, Workgroup supervision: Dublin City University, NICB. 2004-2013; Lecturing, Practical class supervision, Workgroup supervision: NUI Maynooth, Biology Dept. 2013. Research Experience: 3 years University College Dublin, Pharmacology Dept. (Muscular Dystrophy); 1 year NUI Maynooth, Biology Dept. (Muscular Dystrophy; Myasthenia Gravis); 9 years Dublin City University, NICB. (Cancer; Diabetes; Muscle biology). Research Funding & Awards: Ongoing Research Support: Enterprise Ireland CF 2012 2005 - 01/10/2012-30/09/2013 “New Serum Biomarkers for Early Detection of Lung Cancer”. Role: PI, Award: €106,493 Mater Hospital Foundation, Serum protein biomarkers for drug response in Multiple Myeloma patients 2006-2013 Role: Joint PI, Award: €230,000 Completed Research Support Enterprise Ireland PC/2008/0368 - 01/01/2009-31/12/2010 “Validation of a panel of serum biomarkers for use in early detection and monitoring of response to therapy in squamous cell carcinoma of the lung”. Role: Joint PI, Award: €100,000 Currently supervising: 5 Andrew McCann (PhD, DCU): Analysis of conditioned media from cancer cell lines as a source of candidate biomarkers for early detection and therapeutic monitoring. Catriona Hayes (PhD, Mater/Dana Farber): Analysis of the interactions between plasma cells with the micro-environment and its role in Bortezomib resistance. MinYuen Teo (MD, St Vincents/Tallaght): Identification of biomarkers for the early detection of recurrence in colorectal cancer patients. Kay Reen Ting (MD, Mater): Investigating biomarkers predicting response to Bortezomib in Multiple Myeloma patients. Benvon Moran (MD, St James): Examining molecular mechanisms involved in the progression of malignant melanoma. Previously supervised: 1 Rajesh Rajpal (PhD, Mater): Identification of novel protein biomarkers for predicting response to thalidomide-based therapy in newly diagnosed multiple myeloma patients (2007-2011) Damian Pollard (PhD, DCU): Identification of biomarkers for the early detection and therapeutic monitoring in lung cancer (2007-2013).

Research Interest

 Biomedical science